|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rees M, Tekkis PP, Welsh FK, O'Rourke T
and John TG: Evaluation of long-term survival after hepatic
resection for metastatic colorectal cancer: A multifactorial model
of 929 patients. Ann Surg. 247:125–135. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leporrier J, Maurel J, Chiche L, Bara S,
Segol P and Launoy G: A population-based study of the incidence,
management and prognosis of hepatic metastases from colorectal
cancer. Br J Surg. 93:465–474. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Colvin H, Mizushima T, Eguchi H, Takiguchi
S, Doki Y and Mori M: Gastroenterological surgery in Japan: The
past, the present and the future. Ann Gastroenterol Surg. 1:5–10.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giessen C, Laubender RP, Ankerst DP,
Stintzing S, Modest DP, Mansmann U and Heinemann V:
Progression-free survival as a surrogate endpoint for median
overall survival in metastatic colorectal cancer: Literature-based
analysis from 50 randomized first-line trials. Clin Cancer Res.
19:225–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Penfornis P, Vallabhaneni KC, Whitt J and
Pochampally R: Extracellular vesicles as carriers of microRNA,
proteins and lipids in tumor microenvironment. Int J Cancer.
138:14–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Joyce JA and Pollard JW:
Microenvironmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Valadi H, Ekstrom K, Bossios A, Sjostrand
M, Lee JJ and Lotvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kosaka N, Iguchi H, Hagiwara K, Yoshioka
Y, Takeshita F and Ochiya T: Neutral sphingomyelinase 2
(nSMase2)-dependent exosomal transfer of angiogenic microRNAs
regulate cancer cell metastasis. J Biol Chem. 288:10849–10859.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishida N, Nagahara M, Sato T, Mimori K,
Sudo T, Tanaka F, Shibata K, Ishii H, Sugihara K, Doki Y, et al:
Microarray analysis of colorectal cancer stromal tissue reveals
upregulation of two oncogenic miRNA clusters. Clin Cancer Res.
18:3054–3070. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bullock MD, Pickard K, Mitter R, Sayan AE,
Primrose JN, Ivan C, Calin GA, Thomas GJ, Packham GK and Mirnezami
AH: Stratifying risk of recurrence in stage II colorectal cancer
using deregulated stromal and epithelial microRNAs. Oncotarget.
6:7262–7279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kijima T, Hazama S, Tsunedomi R, Tanaka H,
Takenouchi H, Kanekiyo S, Inoue Y, Nakashima M, Iida M, Sakamoto K,
et al: MicroRNA-6826 and −6875 in plasma are valuable noninvasive
biomarkers that predict the efficacy of vaccine treatment against
metastatic colorectal cancer. Oncol Rep. 37:23–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods (San Diego, Calif).
25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Sun Y, Wu H, Yu S, Zhang L, Meng
Y, Liu M, Yang H, Liu P, Mao X, et al: Elevated miR-483-3p
expression is an early event and indicates poor prognosis in
pancreatic ductal adenocarcinoma. Tumour Biol. 36:9447–9456. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iizuka N, Oka M, Yamada-Okabe H, Nishida
M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, et al:
Oligonucleotide microarray for prediction of early intrahepatic
recurrence of hepatocellular carcinoma after curative resection.
Lancet. 361:923–929. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu M and Chen H: The role of microRNAs in
colorectal cancer. J Genet Genomics. 37:347–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vicinus B, Rubie C, Stegmaier N, Frick VO,
Kölsch K, Kauffels A, Ghadjar P, Wagner M and Glanemann M: miR-21
and its target gene CCL20 are both highly overexpressed in the
microenvironment of colorectal tumors: Significance of their
regulation. Oncol Rep. 30:1285–1292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ling H, Pickard K, Ivan C, Isella C, Ikuo
M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, et al: The
clinical and biological significance of MIR-224 expression in
colorectal cancer metastasis. Gut. 65:977–989. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou J, Zhang M, Huang Y, Feng L, Chen H,
Hu Y, Chen H, Zhang K, Zheng L and Zheng S: MicroRNA-320b promotes
colorectal cancer proliferation and invasion by competing with its
homologous microRNA-320a. Cancer Lett. 356:669–675. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim YK, Yu J, Han TS, Park SY, Namkoong B,
Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK and Kim VN: Functional links
between clustered microRNAs: Suppression of cell-cycle inhibitors
by microRNA clusters in gastric cancer. Nucleic Acids Res.
37:1672–1681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsuzaki J and Suzuki H: Role of
MicroRNAs-221/222 in digestive systems. J Clin Med. 4:1566–1577.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F,
Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng
K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell
proliferation and radioresistance by targeting PTEN. BMC Cancer.
10:3672010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanaka R, Tomosugi M, Horinaka M, Sowa Y
and Sakai T: Metformin Causes G1-phase arrest via down-regulation
of MiR-221 and enhances TRAIL sensitivity through DR5 Up-regulation
in pancreatic cancer cells. PLoS One. 10:e01257792015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin J and Luo M: MicroRNA-221 promotes
colorectal cancer cell invasion and metastasis by targeting RECK.
FEBS Lett. 588:99–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang C, Zhang J, Zhang A, Wang Y, Han L,
You Y, Pu P and Kang C: PUMA is a novel target of miR-221/222 in
human epithelial cancers. Int J Oncol. 37:1621–1626.
2010.PubMed/NCBI
|
|
28
|
Zhao JJ, Chu ZB, Hu Y, Lin J, Wang Z,
Jiang M, Chen M, Wang X, Kang Y, Zhou Y, et al: Targeting the
miR-221-222/PUMA/BAK/BAX pathway abrogates dexamethasone resistance
in multiple Myeloma. Cancer Res. 75:4384–4397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Uozaki H, Morita S, Kumagai A, Aso T,
Soejima Y, Takahashi Y and Fukusato T: Stromal miR-21 is more
important than miR-21 of tumour cells for the progression of
gastric cancer. Histopathology. 65:775–783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao L, Sun Y, Hou Y, Peng Q, Wang L, Luo
H, Tang X, Zeng Z and Liu M: MiRNA expression analysis of
cancer-associated fibroblasts and normal fibroblasts in breast
cancer. Int J Biochem Cell Biol. 44:2051–2059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimoda M, Principe S, Jackson HW, Luga V,
Fang H, Molyneux SD, Shao YW, Aiken A, Waterhouse PD, Karamboulas
C, et al: Loss of the Timp gene family is sufficient for the
acquisition of the CAF-like cell state. Nat Cell Biol. 16:889–901.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Garofalo M, Di Leva G, Romano G, Nuovo G,
Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P,
et al: miR-221&222 regulate TRAIL resistance and enhance
tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell.
16:498–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu Q, Li P, Chen X, Zong L, Jiang Z, Nan
L, Lei J, Duan W, Zhang D, Li X, et al: miR-221/222 induces
pancreatic cancer progression through the regulation of matrix
metalloproteinases. Oncotarget. 6:14153–14164. 2015.PubMed/NCBI
|
